July 26 | 2018
Meet us at LSX Nordic Congress
Read more
July 20 | 2018
2cureX continues to update its frequently asked Question page on www.2curex.com
Read more
June 21 | 2018
2cureX presents positive clinical data from its IndiTreat® CRC trial at ESMO in Barcelona
Read more
May 29 | 2018
Clarification of warrants resolved at the Annual General Meeting
Read more
May 24 | 2018
The University Hospital, Rigshospitalet, University Medical Center Hamburg-Eppendorf and 2cureX have initiated a clinical study in ovarian cancer
Read more
May 18 | 2018
2cureX AB publishes interim report for the first financial quarter of 2018
Read more
May 7 | 2018
2cureX AB publishes annual report for the fiscal year 2017
Read more
May 4 | 2018
2cureX releases new information brochure
Read more
May 2 | 2018
2cureX’s CEO Ole Thastrup will join Folkemødet 2018 in Denmark
Read more
April 24 | 2018
2cureX is expanding its operations in Germany with the opening of a screening lab at Centrum für innovative Medizin (CiM), Hamburg
Read more
March 13 | 2018
2cureX receives first payment of EUR 1,5 million from EU Horizon 2020
Read more
March 12 | 2018
2cureX invited to present IndiTreat® and clinical data at ESMO in June 2018
Read more
February 27 | 2018
2cureX will participate at Sedermeradagen Copenhagen
Read more
January 22 | 2018
2cureX agrees on final terms concerning an EUR 3 million grant from Horizon 2020
Read more
December 11 | 2017
Large interest in the newly launched clinical trial for 2cureX’s IndiTreat™ test
Read more
November 29 | 2017
2cureX prepares for market launch of IndiTreat™ in 2020 – international Chief Business Officer is recruited to lead the process
Read more
November 2 | 2017
2cureX AB: rights issue ahead of the planned listing on the Nasdaq OMX Stockholm First North was heavily oversubscribed
Read more